- The World Health Organization extends "prequalification status" to Sanofi's (SNY +0.6%) Shan5 vaccine. This allows United Nations agencies like UNICEF to purchase the product.
- Sanofi developed Shan5 with the Indian biotech firm Shantha. It was cleared for sale in that country in March.
- The vaccine protects children from diptheria, tetanus, pertussis, Hib and hep B.